Close Menu

NEW YORK (GenomeWeb) – Danaher today released its earnings guidance for 2017, saying that it anticipates net earnings per share of $3.13 to $3.23.

On an adjusted basis, the company expects earnings of $3.85 to $3.95 per share, which assumes core revenue growth of 3 percent to 4 percent over 2016. The current average analyst estimate for earnings per share in 2017 is $3.95.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports that the CDC's SARS-CoV-2 test issues reflect earlier ones it had with Zika virus testing.

NPR writes that even with thousands of new COVID-19 papers, each should be evaluated based on its own quality.

Researchers traced a gene cluster linked to COVID-19 severity to Neanderthals, the New York Times reports.

In PNAS this week: soil bacteria-derived small molecules affect centrosomal protein, microfluidics approach for capturing circulating tumor cells, and more.